Sanguina

Norcross, United States

Sanguina is a wellness and diagnostic company offering at-home anemia management tools, through app technology and an over-the-counter kit.

$2.8M raised

Jul 2023

Series A

Top Investors

National Science FoundationXRC VenturesGeorgia Research AllianceThe Seed LabVeritus Holdings

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Sanguina raised?

Sanguina has raised $2.8M in total funding. The most recent round was Series A. The last funding was announced in July 2023.

Who are Sanguina's investors?

Sanguina's investors include National Science Foundation, XRC Ventures, Georgia Research Alliance, The Seed Lab, Veritus Holdings.

Where is Sanguina headquartered?

Sanguina is headquartered in Norcross, United States.

What does Sanguina do?

Sanguina is a wellness and diagnostic company offering at-home anemia management tools, through app technology and an over-the-counter kit.

What stage is Sanguina at?

Sanguina is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 25, 2023.

MLA

"Sanguina — Funding & Investors." VCBacked, July 25, 2023, https://www.vcbacked.co/company/sanguina. Accessed June 17, 2026.

APA

VCBacked. (2023). Sanguina — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/sanguina

Wikipedia (cite web)

{{cite web |title=Sanguina — Funding & Investors |url=https://www.vcbacked.co/company/sanguina |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 25, 2023.